N.M. Stat. § 9-17-9
Interagency pharmaceuticals purchasing council; creation;
membership; duties.
A. The "interagency pharmaceuticals purchasing council" is created and is
administratively attached to the general services department. The council shall:
(1)
review and coordinate cost-containment strategies for the procurement of
pharmaceuticals and pharmacy benefits and the pooling of risk for pharmacy services
by the constituent agencies;
(2)
identify ways to leverage constituent agencies' pharmaceutical and
pharmacy benefits procurement to maximize the purchasing power of New Mexico
residents purchasing pharmaceuticals or pharmacy benefits in the private sector; and
(3)
identify other cost-saving opportunities for New Mexico residents
purchasing pharmaceuticals or pharmacy benefits in the private sector.
B. Pursuant to its review of these strategies and related data, the interagency
pharmaceuticals purchasing council shall decide by vote which cost-containment
strategies it will recommend. Constituent agencies shall make their own procurement
decisions. The secretary of general services shall serve as director of the council and
shall be responsible for the coordination of the day-to-day activities of the council.
C. The interagency pharmaceuticals purchasing council shall be composed of the
following eleven members serving as voting, ex-officio members:
(1)
the secretary of human services or the secretary's designee;
(2)
the secretary of health or the secretary's designee;
(3)
the secretary of children, youth and families or the secretary's designee;
(4)
the secretary of corrections or the secretary's designee;
(5)
the director of the risk management division of the general services
department or the director's designee;
(6)
the executive director of the retiree health care authority or the executive
director's designee;
(7)
the executive director of the public school insurance authority or the
executive director's designee;
(8)
the superintendent of the Albuquerque public school district or the
superintendent's designee;
(9)
the president of the university of New Mexico or the president's designee;
and
(10)
two members, appointed by the governor, who are officers of, or
representative of organizations that represent, county, municipal or local government
entities that participate in consolidated purchasing of pharmaceuticals or pharmacy
benefits with other constituent agencies.
D. The interagency pharmaceuticals purchasing council shall convene its first
meeting by September 1, 2019 at the call of the secretary of general services. After the
initial meeting of the council, it shall meet at least once quarterly at the call of the
secretary of general services. Meetings of the council shall be subject to the Open
Meetings Act [Chapter 10, Article 15 NMSA 1978]. In addition to notice provided
pursuant to that act, the secretary of general services shall provide written notice of
each scheduled meeting of the council to the director of the legislative finance
committee at least ten days before each meeting.
E. The interagency pharmaceuticals purchasing council shall review and coordinate
cost-containment strategies for the procurement of pharmaceuticals and pharmacy
benefits and the pooling of risk for pharmacy services by the constituent agencies. The
cost-containment strategies that the council shall examine shall include:
(1)
the benchmarking of pricing for pharmaceuticals and pharmacy benefits to
the pricing that the state's medical assistance plans achieve for pharmaceuticals and
pharmacy benefits; provided that the human services department [health care authority
department] shall seek federal authorization prior to making any changes to medical
assistance pharmaceuticals purchasing or pharmacy benefits;
(2)
active medical management to optimize health outcomes and reduce
costs;
(3)
the establishment of a common formulary for all pharmaceuticals and
pharmacy benefits plans offered by constituent agencies;
(4)
a single purchase agreement for all constituent agencies' pharmaceuticals
and pharmacy benefits;
(5)
common procurement of expert services, including, at minimum,
pharmacy benefits management, pharmacy benefits management oversight services,
medical direction and actuarial services;
(6)
identifying any opportunities to consolidate purchasing among two or more
constituent agencies;
(7)
identifying any opportunities for pooling risk among two or more
constituent agencies or populations the constituent agencies serve;
(8)
identifying any opportunities for consolidating purchasing with other
entities and states of the United States;
(9)
ensuring that all agencies, programs, clinics, hospitals and other health-
related centers and entities, including those identified by the human services
department [health care authority department] pursuant to Paragraph (3) of Subsection
A of Section 27-2-12.13 NMSA 1978, that are eligible for pharmaceutical discounts
pursuant to Section 340B of the federal Public Health Service Act participate in that
Section 340B federal pharmaceutical price discount program;
(10)
identifying any opportunities for maximizing the use of generic
pharmaceuticals where safe and cost-effective to do so;
(11)
negotiating advantageous pricing and incentives with insurers, pharmacy
benefits managers, pharmacies, manufacturers, distributors and vendors of
pharmaceuticals and other third-party entities involved in supplying pharmaceuticals,
pharmacy benefits and management services to the council's constituent entities;
(12)
identifying ways to leverage constituent agencies' pharmaceutical and
pharmacy benefits procurement to maximize the purchasing power of New Mexico
residents purchasing pharmaceuticals and pharmacy benefits in the private sector;
(13)
identifying other cost-saving opportunities for New Mexico residents
purchasing pharmaceuticals or pharmacy benefits in the private sector; and
(14)
identifying any other opportunities for maximizing efficiency and a high
standard of health care quality.
F. The legislative finance committee shall annually review and validate the
interagency pharmaceuticals purchasing council's progress. The legislative finance
committee shall incorporate this information into its budget and policy analysis and
recommendations for the council or any of the council's implementing constituent
agencies.
G. As used in this section, "constituent agency" means:
(1)
the human services department [health care authority department],
including any medical assistance program it administers;
(2)
the department of health;
(3)
the children, youth and families department;
(4)
the corrections department;
(5)
the risk management division of the general services department;
(6)
the retiree health care authority;
(7)
the public school insurance authority;
(8)
the publicly funded health care program of the Albuquerque public school
district;
(9)
the university of New Mexico health benefits program for university
employees and retirees;
(10)
the university of New Mexico hospitals; or
(11)
any local, county or municipal government that opts to participate in
consolidated pharmaceuticals or pharmacy benefit purchasing.